A Breath THC Cutoff Can Be Analytical Without Being an Impairment Threshold

A breath assay’s reporting cutoff does not become an impairment threshold merely because the method accurately measures THC. A Cannabix collection-and-analysis study validated analytical procedures, not a concentration that identifies unsafe driving.

What was calibrated

The procedure collected a specified breath volume onto cartridges and used LC–MS/MS to separate delta-9 THC, delta-8 THC, CBD and cannabinol. Calibrators and quality controls were prepared by adding reference compounds to unused collection pods.

Cartridge calibration establishes the relationship between loaded analyte and laboratory response. It is distinct from proving how efficiently the complete device captures every person’s exhaled cannabinoid across different breathing patterns and conditions.

The human application had naturalistic dosing

Participants smoked their own cannabis ad libitum, with reported product potencies, and provided samples before and after use. Ambient-air collections were included. This demonstrates application to actual breath samples, but does not standardize absorbed dose.

The study’s analytical cutoff, including a 5-pg/L example, should be identified as a method-specific reporting decision. It was not derived by validating the boundary against driving outcomes in this experiment.

Split samples answer a different question

The collection system allows separately sealed primary and confirmatory samples. Preserving material for another analysis is valuable for review and chain of custody. It does not, by itself, validate the inference from a concentration to impairment.

Separate laboratory analysis can investigate identity and concentration while leaving unresolved whether the measured exposure caused a particular functional deficit.

A useful assessment separates the layers

Ask about collection volume, capture performance, cartridge recovery, blanks, calibration, analyte separation and repeat analysis. Then ask whether a separate study validates the proposed behavioral interpretation in the relevant population.

This paper supports an analytical breath-testing workflow and documents actual post-smoking samples. It does not establish a universal breath detection window, a legal limit or an individual driving-impairment classifier. Those additional claims require their own evidence.

For context, see our discussion of THC concentrations and the separate question of impairment.

Primary research

Shaza Deeb and colleagues. Simultaneous analysis of Δ9-THC, Δ8-THC, CBD, and CBN in breath aerosols collected using cannabix technologies breath collection unit. Journal of Analytical Toxicology (2026). DOI: 10.1093/jat/bkag016.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Baseline Breath THC and Post-Use Results Told Different Stories

A relationship between blood and breath THC before smoking did not persist in the same way at the study’s post-smoking peak assessment. This finding cautions against treating one correlation as a universal conversion between specimens or proof of impairment. Different subsets answered different questions Wurz and DeGregorio analyzed data from…

Spread the love

Read Article: Baseline Breath THC and Post-Use Results Told Different Stories

A Sensitive Plasma THC Assay Still Needed Additional Forensic Validation

A low detection limit does not establish that an assay has answered every forensic identification question. A 2017 plasma cannabinoid method illustrates this clearly: the authors reported strong quantitative performance while expressly identifying validation steps needed for a different use. What the method was designed to do Andrenyak and colleagues…

Spread the love

Read Article: A Sensitive Plasma THC Assay Still Needed Additional Forensic Validation

Urinary CBD Peaks Differed After Oral and Vaporized Dosing

The same nominal CBD dose produced different urinary profiles after oral and vaporized administration in a controlled human study. Those profiles describe excretion under the study conditions; they do not provide a reliable clock for an individual’s last use or an impairment threshold. The specimen was urine The study examined…

Spread the love

Read Article: Urinary CBD Peaks Differed After Oral and Vaporized Dosing

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us